DLX Holdings Corp., (DLX) the subsidiary of our company, was registered in December 2012, and is the parent company of Delex Pharma International Inc. (DPI). DLX is engaged in the development, distribution and trading of medical supplies, equipment, pharmaceutical products, and food supplements.
Delex Pharma International, Inc. (DPI), a socially accountable Filipino-owned and ISO 9001:2015-certified company, has continuously served its nationwide market for fourteen years. The company is 60% owned by DLX Holdings, Inc. and 40% owned by High Everest Capital Inc.
JMN Brothers Pharma Limited, Inc., a subsidiary company of Delex Pharma, was founded in the Philippines on June 27, 2016, by the management heading the latter organization. Although it is a new player in the market, it has slowly made rounds to become one of the trusted companies in the country, focusing on women’s health and ethical products.
[stock-market-overview stockExchange=”bncm” width=”100%” allowSort=”false” includeChart=”false” logoMaxHeight=”20px” logoMaxWidth=”90px” height=”100%”]